Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ATNX

Athenex

$16.66

-0.11 (-0.66%)

08:25
02/20/18
02/20
08:25
02/20/18
08:25
Hot Stocks
Athenex announces Phase II clinical study results for KX2-391 ointment »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Wednesday
ATNX

Athenex

$15.29

0.28 (1.87%)

08:07
02/14/18
02/14
08:07
02/14/18
08:07
Hot Stocks
Athenex completes patients enrollment for 2 Phase III studies of KX2-391 »

Athenex announced early…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ATNX

Athenex

$15.47

0.99 (6.84%)

07:02
01/25/18
01/25
07:02
01/25/18
07:02
Syndicate
Athenex 4.3M share Secondary priced at $15.25 »

Deutsche Bank and RBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

ATNX

Athenex

$17.33

0.12 (0.70%)

07:36
01/22/18
01/22
07:36
01/22/18
07:36
Syndicate
Athenex files to sell 4.3M shares of common stock »

Deutsche Bank Securities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$17.33

0.12 (0.70%)

07:04
01/22/18
01/22
07:04
01/22/18
07:04
Hot Stocks
Athenex announces results of first cohort of Phase 1b clinical trial of Oraxol »

Athenex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ATNX

Athenex

$15.95

0.08 (0.50%)

06:41
01/17/18
01/17
06:41
01/17/18
06:41
Recommendations
Athenex analyst commentary at Deutsche Bank »

Athenex feedback from FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$15.87

0.15 (0.95%)

08:23
01/16/18
01/16
08:23
01/16/18
08:23
Hot Stocks
Athenex receives 'positive' feedback from FDA on design of Oraxol clinical trial »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$15.57

-0.04 (-0.26%)

08:37
01/08/18
01/08
08:37
01/08/18
08:37
Hot Stocks
Athenex announces Chinese FDA allowance of IND application for Oraxol »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$16.70

0.07 (0.42%)

08:07
12/27/17
12/27
08:07
12/27/17
08:07
Hot Stocks
Athenex granted PIM designation from UK MHRA for Oraxol »

Athenex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKCA

Akcea Therapeutics

$18.60

-0.06 (-0.32%)

, ATNX

Athenex

$16.46

-0.28 (-1.67%)

08:30
12/21/17
12/21
08:30
12/21/17
08:30
Options
Ten new option listings and one option delisting on December 21st »

New option listings for…

AKCA

Akcea Therapeutics

$18.60

-0.06 (-0.32%)

ATNX

Athenex

$16.46

-0.28 (-1.67%)

LAKE

Lakeland Industries

LIFE

aTyr Pharma

$3.80

0.25 (7.04%)

PVAC

Penn Virginia

$39.04

1.31 (3.47%)

RDHL

RedHill Biopharma

$4.80

-0.07 (-1.44%)

RESN

Resonant

$8.20

0.4 (5.13%)

SSC

Seven Stars Cloud Group

$5.57

1.24 (28.64%)

VBIV

VBI Vaccines

$4.40

0.14 (3.29%)

VIVE

Viveve

$5.14

0.07 (1.38%)

PLPM

Planet Payment

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.